US OptionsDetailed Quotes
CDTX241220C7500
- 0.00
- 0.000.00%
15min DelayClose Nov 29 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest7.50Strike Price0.00Turnover0.00%IV-62.89%PremiumDec 20, 2024Expiry Date12.71Intrinsic Value100Multiplier19DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma--Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Cidara Therapeutics Stock Discussion
Sign in to post a comment
This is a list in progress
NOTE:
1. Not all of these stocks will go up. Everything relies on market sentiment/buy pressure, the satanic shorts including dark pool.
2. The SI CTB and shorts availability are based on 11/29 data and may get updated Monday.
$New Horizon Aircraft (HOVR.US)$ Up after hours. EVTOL company. Reason? It terminated its FPA which will result in an estimated gain of $20-25 million for Horizon in Q2 ENDIN...
NOTE:
1. Not all of these stocks will go up. Everything relies on market sentiment/buy pressure, the satanic shorts including dark pool.
2. The SI CTB and shorts availability are based on 11/29 data and may get updated Monday.
$New Horizon Aircraft (HOVR.US)$ Up after hours. EVTOL company. Reason? It terminated its FPA which will result in an estimated gain of $20-25 million for Horizon in Q2 ENDIN...
3
3
$Cidara Therapeutics (CDTX.US)$
Cidara Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(9.99%),Peter Kolchinsky(9.99%), etc.
Cidara Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(9.99%),Peter Kolchinsky(9.99%), etc.
$Cidara Therapeutics (CDTX.US)$ On my top watchlist.
Cash available will sustain the operations for 24 months (exclude 105mil private placement). Upcoming catalyst September 2025.
Cash available will sustain the operations for 24 months (exclude 105mil private placement). Upcoming catalyst September 2025.
$Cidara Therapeutics (CDTX.US)$ Cidara Therapeutics to Raise $105M Via Private Placement >CDTX
$Cidara Therapeutics (CDTX.US)$
Cidara Therapeutics Announces First Subjects Dosed in Phase 2b NAVIGATE Trial Evaluating CD388 for the Prevention of Seasonal Influenzau
SAN DIEGO, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ:CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, today announced the first sub...
Cidara Therapeutics Announces First Subjects Dosed in Phase 2b NAVIGATE Trial Evaluating CD388 for the Prevention of Seasonal Influenzau
SAN DIEGO, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ:CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, today announced the first sub...
$Cidara Therapeutics (CDTX.US)$ Cidara Therapeutics: Closed a $240M Private Placement Led by RA Cap Management >CDTX
Dow Jones· 1 min ago
Dow Jones· 1 min ago
No comment yet
105642463xu : $KULR Technology (KULR.US)$
Jaguar8 OP 105642463xu : Yup its on my watchlist
Rosscco : Thanks for the tip !